Literature DB >> 18396074

Combined PET-FDG and USPIO-enhanced MR imaging in patients with symptomatic moderate carotid artery stenosis.

T Y Tang1, R R Moustafa, S P Howarth, S R Walsh, J R Boyle, Z Y Li, J-C Baron, J H Gillard, E A Warburton.   

Abstract

INTRODUCTION: PET-FDG and USPIO-enhanced MRI are increasingly being used in depicting carotid atheroma inflammation--a risk factor for the high risk plaque. Their combined use has not been previously reported. REPORT: Two patients presenting with stroke and identified with 50% carotid stenosis on duplex ultrasonography, underwent PET FDG and USPIO-enhanced MR imaging. Results were concordant and complementary suggesting that both techniques reflect similar metabolic processes. DISCUSSION: The selection of patients for carotid revascularisation has largely been based on the severity of luminal stenosis alone. The two imaging modalities, which identify inflammatory activity, may be potential surrogate risk markers in the selection of patients eligible for carotid surgery, if plaque inflammation can be correlated with risk of developing clinical symptoms.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18396074     DOI: 10.1016/j.ejvs.2008.02.006

Source DB:  PubMed          Journal:  Eur J Vasc Endovasc Surg        ISSN: 1078-5884            Impact factor:   7.069


  10 in total

Review 1.  Noninvasive imaging of atheromatous carotid plaques.

Authors:  Umar Sadat; Zhi-Yong Li; Martin J Graves; Tjun Y Tang; Jonathan H Gillard
Journal:  Nat Clin Pract Cardiovasc Med       Date:  2009-03

2.  Capping it off.

Authors:  H William Strauss
Journal:  J Nucl Cardiol       Date:  2009-07-25       Impact factor: 5.952

3.  Progress in atherosclerotic plaque imaging.

Authors:  Giulia Soloperto; Sergio Casciaro
Journal:  World J Radiol       Date:  2012-08-28

Review 4.  Sequential whole-body PET/MR scanner: concept, clinical use, and optimisation after two years in the clinic. The manufacturer's perspective.

Authors:  Antonis Kalemis; Bénédicte M A Delattre; Susanne Heinzer
Journal:  MAGMA       Date:  2012-08-07       Impact factor: 2.310

Review 5.  Imaging biomarkers of cardiovascular disease.

Authors:  Jinnan Wang; Niranjan Balu; Gador Canton; Chun Yuan
Journal:  J Magn Reson Imaging       Date:  2010-09       Impact factor: 4.813

Review 6.  Nanoparticles as magnetic resonance imaging contrast agents for vascular and cardiac diseases.

Authors:  Wei Chen; David P Cormode; Zahi A Fayad; Willem J M Mulder
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2010-10-21

Review 7.  Monocyte and Macrophage Dynamics in the Cardiovascular System: JACC Macrophage in CVD Series (Part 3).

Authors:  Zahi A Fayad; Filip K Swirski; Claudia Calcagno; Clinton S Robbins; Willem Mulder; Jason C Kovacic
Journal:  J Am Coll Cardiol       Date:  2018-10-30       Impact factor: 24.094

Review 8.  Inflammation and neovascularization intertwined in atherosclerosis: imaging of structural and molecular imaging targets.

Authors:  Umar Sadat; Farouc A Jaffer; Marc A M J van Zandvoort; Stephen J Nicholls; Domenico Ribatti; Jonathan H Gillard
Journal:  Circulation       Date:  2014-08-26       Impact factor: 29.690

Review 9.  Myocardial inflammation and energetics by cardiac MRI: a review of emerging techniques.

Authors:  Vasiliki Tsampasian; Andrew J Swift; Hosamadin Assadi; Amrit Chowdhary; Peter Swoboda; Eva Sammut; Amardeep Dastidar; Jordi Broncano Cabrero; Javier Royuela Del Val; Sunil Nair; Robin Nijveldt; Alisdair Ryding; Chris Sawh; Chiara Bucciarelli-Ducci; Eylem Levelt; Vassilios Vassiliou; Pankaj Garg
Journal:  BMC Med Imaging       Date:  2021-11-08       Impact factor: 1.930

Review 10.  MR/PET Imaging of the Cardiovascular System.

Authors:  Philip M Robson; Damini Dey; David E Newby; Daniel Berman; Debiao Li; Zahi A Fayad; Marc R Dweck
Journal:  JACC Cardiovasc Imaging       Date:  2017-10
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.